A tear film-inspired biomimetic strategy with enhanced lubrication, anchoring, and antioxidative properties for dry eye disease
Source abstract
Abstract
Dry eye disease (DED) is a multifactorial ocular surface disorder driven by tear film instability, excessive evaporation, frictional damage, oxidative stress, and epithelial injury. Current artificial tears mainly replenish aqueous volume and provide lubrication, but they may not adequately reproduce the coordinated interfacial functions of the native tear film that contribute to ocular surface stability. Here, we reported a tear film-inspired biomimetic strategy based on two complementary hyaluronic acid (HA) derivatives for the treatment of DED. HP was engineered by grafting zwitterionic poly(2-methacryloyloxyethyl phosphorylcholine) side chains onto HA to generate a highly hydrated, anti-evaporative, and low-friction interface, whereas HD was constructed by conjugating dopamine to HA to enhance ocular surface anchoring and provide intrinsic antioxidant activity. The integrated HP/HD system exhibited enhanced water retention, favorable shear-thinning behavior, and superior lubrication performance. Transverse relaxation (T2) NMR analysis further supported the key role of the zwitterionic hydration layer in interfacial lubrication. Quartz crystal microbalance with dissipation monitoring, fluorescence quenching, FTIR, in vitro and in vivo retention studies showed that HD strengthened mucin interaction and prolonged ocular surface residence. In addition, the catechol-containing component endowed the system with effective free-radical-scavenging capacity and intracellular reactive oxygen species suppression. In a benzalkonium chloride-induced guinea pig model of DED, topical administration of HP/HD significantly improved tear secretion, accelerated corneal epithelial repair, promoted goblet cell recovery, and reduced corneal oxidative stress compared with the commercial lubricant control. Collectively, this work establishes a tear film-inspired biomimetic strategy that integrates anti-evaporation, hydration lubrication, surface anchoring, and antioxidation within a system, offering a promising material approach for DED therapy. STATEMENT OF SIGNIFICANCE: Dry eye disease (DED) causes severe discomfort and surface damage. Current treatments for DED primarily rely on transient aqueous supplementation, which fails to reconstruct the hierarchical architecture of the native tear film and is limited by rapid precorneal clearance. To overcome this fundamental limitation, we proposed a tear film inspired biomimetic strategy. By integrating zwitterionic hydration lubrication (via PMPC-grafted hyaluronic acid) with catechol-mediated mucoadhesion and active antioxidant defense, our system synergistically reconstructs the physiological "mucin-aqueous-lipid" interface. Functionally, this system integrates anti-evaporation, moisturizing lubrication, surface anchoring, and antioxidant protection, effectively breaking the vicious cycle of DED self-reinforcement. This work provides a physiologically informed biomaterial strategy that shifts the paradigm of DED management from passive moisture supplementation to overall tear film reconstruction.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Ocular Surface and Contact Lens · Advanced Drug Delivery Systems · Corneal Surgery and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Nanoceria-mediated cyclosporin a delivery for dry eye disease management through modulating immune–epithelial crosstalk10.1021/acsnano.3c11514 ↗
2. Aminated fullerene for comprehensive dry eye therapy: promoting epithelial-barrier reconstruction and nerve regeneration by suppressing oxidation and inflammation10.1016/j.biomaterials.2025.123329 ↗
3. A multifunctional mitochondria-targeted nanoparticle for the effective treatment of dry eye disease via reactive oxygen species scavenging
4. Multifunctional hydrogel eye drops for synergistic treatment of ocular inflammatory disease10.1021/acsnano.3c08869 ↗
5. Mussel-inspired microgel encapsulated NLRP3 inhibitor as a synergistic strategy against dry eye10.3389/fbioe.2022.913648 ↗
6. Advances and limitations of drug delivery systems formulated as eye drops10.1016/j.jconrel.2020.01.057 ↗
7. Recent advances of smart materials for ocular drug delivery10.1016/j.addr.2023.115006 ↗
8. Microneedles for advanced ocular drug delivery10.1016/j.addr.2023.115082 ↗
9. TFOS DEWS II tear film report10.1016/j.jtos.2017.03.006 ↗
10. Tear film lipid layer: a molecular level view10.1016/j.bbamem.2016.02.020 ↗
11. Biomimetic cartilage-lubricating polymers regenerate cartilage in rats with early osteoarthritis10.1038/s41551-021-00785-y ↗
12. Friction measurements on contact lenses in a physiologically relevant environment: effect of testing conditions on Friction10.1167/iovs.16-19713 ↗
13. Lubricity of surface hydrogel layers10.1007/s11249-012-0076-8 ↗
14. Aqueous one-pot synthesis of well-defined zwitterionic diblock copolymers by RAFT polymerization: an efficient and environmentally-friendly route to a useful dispersant for aqueous pigments10.1039/D0GC04271D ↗
15. Dopamine-modified hyaluronic acid hydrogel adhesives with fast-forming and high tissue adhesion10.1021/acsami.9b22120 ↗
16. Shear-thinning and temperature-dependent viscosity relationships of contemporary ocular lubricants10.1167/tvst.11.3.1 ↗
17. Shear-stress-dependent viscous properties of hyaluronic-based lubricants10.3390/jcm14248753 ↗
18. pH-induced metal-ligand cross-links inspired by mussel yield self-healing polymer networks with near-covalent elastic moduli
19. Fundamental, mechanism and development of hydration lubrication: from bio-inspiration to artificial manufacturing10.1016/j.cis.2024.103145 ↗
20. The role of hyaluronic acid in cartilage boundary lubrication10.3390/cells9071606 ↗
21. Recent advances in biomimetic related lubrication10.3390/lubricants12110377 ↗
22. Lubrication at physiological pressures by polyzwitterionic brushes10.1126/science.1169399 ↗
23. Time-domain NMR elucidates fibril formation in methylcellulose hydrogels10.1021/acs.macromol.2c02550 ↗
24. Water diffusion and uptake in injectable ETTMP/PEGDA hydrogels10.1021/acs.jpcb.3c00861 ↗
25. Mussel-inspired hydrogel applied to wound healing: a review and future prospects10.3390/biomimetics10040206 ↗
26. Optimal design for studying mucoadhesive polymers interaction with gastric mucin using a quartz crystal microbalance with dissipation (QCM-D): comparison of two different mucin origins10.1016/j.ejpb.2015.08.002 ↗
27. Improving the lubricity of commercial mucins via conjugation with catechol-like molecules
28. Study of hydration repulsion of zwitterionic polymer brushes resistant to protein adhesion through molecular simulations10.1021/acsami.3c18546 ↗
29. Dopamine-conjugated hyaluronic acid hydrogel interpenetrated by genipin crosslinked quaternary ammonium chitosan for potential biomedical adhesives applications10.1016/j.colsurfb.2025.114683 ↗
30. Ocular bio-lubricating materials: from lubrication mechanism to dry eye syndrome treatment10.1093/rb/rbaf121 ↗
31. Modulating mucin hydration and lubrication by deglycosylation and polyethylene glycol binding10.1002/admi.201500308 ↗
32. Mussel-inspired cross-linking mechanisms enhance gelation and adhesion of multifunctional mucin-derived hydrogels
33. Brushing up on cartilage lubrication: polyelectrolyte-enhanced tribological rehydration10.1021/acs.langmuir.4c00598 ↗
34. Reflection absorption infrared spectroscopy characterization of SAM formation from 8-mercapto-N-(phenethyl) octanamide thiols with phe ring and amide groups10.3390/molecules25235633 ↗
35. Ocular drug delivery systems: an overview10.5497/wjp.v2.i2.47 ↗
36. Ophthalmic drug delivery systems for antibiotherapy—a review10.3390/pharmaceutics10010010 ↗
37. Nanomedicines for dry eye syndrome: targeting oxidative stress with modern nanomaterial strategies10.3390/molecules29163732 ↗
38. Adhesive catechol-conjugated hyaluronic acid for biomedical applications: a mini review10.3390/app11010021 ↗
39. The chemistry behind catechol-based adhesion10.1002/anie.201801063 ↗
40. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients10.1016/j.exer.2015.02.013 ↗
41. Applications of nanoparticles in ophthalmology10.1016/j.preteyeres.2010.08.002 ↗
42. Catechol-functionalized hydrogels: biomimetic design, adhesion mechanism, and biomedical applications10.1039/C9CS00285E ↗
43. Safety and toxicity of nanomaterials for ocular drug delivery applications10.3109/17435390.2016.1153165 ↗
44. Pharmacokinetic aspects of retinal drug delivery10.1016/j.preteyeres.2016.12.001 ↗
45. Potential protective and therapeutic roles of the Nrf2 pathway in ocular diseases: an update
46. Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome
47. Advances in the diagnosis and treatment of dry eye10.1016/j.preteyeres.2020.100842 ↗
48. Regulation of UV-B-induced inflammatory mediators by activity-dependent neuroprotective protein (ADNP)-derived peptide (NAP) in corneal epithelium10.3390/ijms24086895 ↗
49. Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins10.1016/j.exer.2013.07.027 ↗